BRAF and melanoma: Low expression of PMCA4b was detected in highly metastatic BRAF mutant melanoma cell lines, in which re-expression of PMCA4b was associated with decreased migration and metastatic activities suggesting a metastasis suppressor role for this PMCA variant11.